Neurogene
Hiram Valencia possesses extensive experience in Information Technology leadership across various biotech and pharmaceutical organizations. Currently serving as the Vice President of Information Technology at Neurogene Inc. since September 2024, Hiram is responsible for IT strategy development and digital transformation initiatives. Previously held the position of Vice President of Information Technology at Krystal Biotech, Inc., and Head of Information Technology at Collegium Pharmaceutical, Inc., where strategic direction and operational efficiency were prioritized. Hiram's expertise also includes significant roles at Alexion Pharmaceuticals, Novartis, and Eli Lilly and Company, contributing to digital transformation, optimization of business applications, and operational excellence. Hiram began a career in engineering with NASA, excelling in software and systems engineering roles. Academic qualifications include an MBA in Accounting and Finance and a BSEE in Electrical Engineering from the University of Puerto Rico.
This person is not in any teams
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.